|

Evaluation Study of Medical-Social Collaboration Model for Middle-aged and Older Adults With Depressive Symptoms

RECRUITINGN/ASponsored by The University of Hong Kong
Actively Recruiting
PhaseN/A
SponsorThe University of Hong Kong
Started2025-08
Est. completion2027-06
Eligibility
Age45 Years+
Healthy vol.Accepted

Summary

The goal of this clinical trial is to learn if a medical-social collaboration model works to reduce depressive symptoms in middle-aged and older adults with subsyndromal depressive symptoms who are waiting for their first psychiatric appointment. Secondary outcomes of the study include reduced anxiety symptoms, reduced loneliness, reduced rumination, reduced self-criticism, improved self-reassurance, improved resilience, improved self-efficacy, improved health-related quality of life, as well as improved quality-adjusted life years, and reduced healthcare service utilisation. Researchers will compare a medical-social collaboration model to a self-management booklet. Participants will: * Receive CBT-based stepped-care interventions through the medical-social collaboration model or a self-management booklet. * Complete a survey about their mental health and service use every three months until their first psychiatric appointment.

Eligibility

Age: 45 Years+Healthy volunteers accepted
Inclusion Criteria:

* Currently awaiting psychiatric services provided by the Hospital Authority
* Have depressive symptoms of at least mild severity
* Able to provide informed consent

Exclusion Criteria:

* A known history of autism spectrum disorder, intellectual disability, schizophrenia-spectrum disorder, bipolar disorder, Parkinson's disease, or dementia
* Imminent suicidal risk (temporary exclusion)
* Communication difficulties that preclude participation

Conditions1

Depression

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.